Pacific Biosciences Of California (PACB) Return on Invested Capital (2022 - 2026)

Pacific Biosciences Of California's Return on Invested Capital history runs 5 years deep, the most recent figure standing at 0.35% for Q1 2026.

• In Q1 2026, Return on Invested Capital fell 32.0% year-over-year to 0.35%; the TTM figure through Mar 2026 stood at 0.35% (down 32.0% YoY), while the FY2025 annual figure was 0.02%, down 1.0% from the prior year.
• Return on Invested Capital was 0.35% for Q1 2026 at Pacific Biosciences Of California, down from 0.27% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q3 2023 to a low of 0.35% in Q1 2026.
• Historically, Return on Invested Capital has averaged 0.08% across 5 years, with a median of 0.01% in 2024.
• The sharpest annual moves came in 2023 and 2026: Return on Invested Capital changed 0 bps in 2023, then sank 32 bps in 2026.
• A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2022, then grew by 5 bps to 0.0% in 2023, then slumped by 140 bps to 0.01% in 2024, then tumbled by 2603 bps to 0.27% in 2025, then decreased by 30 bps to 0.35% in 2026.
• The last three Return on Invested Capital figures came in at 0.35% (Q1 2026), 0.27% (Q4 2025), and 0.14% (Q3 2025), per Business Quant data.